Immunomodulators Market Size is projected to reach USD 235.6 Billion by 2032, growing at a (CAGR) of 7.5%
The global size of the immunomodulators market reached USD 125.4 Billion in 2022 and is projected to achieve USD 235.6 Billion by 2032, demonstrating a rapid revenue compound annual growth rate (CAGR) of 7.5% throughout the forecast period. Key drivers behind the market's revenue growth include the increasing prevalence of autoimmune diseases, growing demand for biologics, and a rising public awareness of the benefits of immunomodulators in treating various disorders.
